wallstreetstocks

Novacyt ALNOV

看多
EURONEXT:ALNOV   NOVACYT
They have marked the supports and resistances of ALNOV .
It has great upside potential, key level reaching $ 5
Last Friday news Clinical diagnostics specialist Novacyt announced on Friday thatots ‘genesig’ Covid-19 real-time PCR test has been approved in the UK. Great news and great upside potential.

A cordial greeting.
In Spain on 12/28/2021 L.E.D.
Wish you all the best and a happy New Year

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。